Abstract:Recently, human hair keratin has been widely studied and applied in clinical fields due to its good histocompatibility, biocompatibility, and biodegradability. However, the regenerated keratin from human hair cannot be electrospun alone because of its low molecular weight. Herein, gamma polyglutamic acid (γ-PGA) was first selected to fabricate smooth and uniform γ-PGA/keratin composite scaffolds with excellent biocompatibility and biodegradability by electrospinning technology and a chemical cross-linking meth… Show more
“…6) was thin (with 28% mean) compared to a much thicker reaction in pacemaker implants in the mm range at ~ 100% of the dermis thickness [24]. The paper's objective outcome correlated with numerous previous studies on extracted and reassembled keratins and KAPs or the broad term "keratin biomaterials," with or without other accepted polymeric biomaterials, showing good in vitro and in vivo biocompatibilities [10,12,[33][34][35]. In the absence of the hair follicle which is the antigenic region [36] containing intact living cells, the terminal hair shaft or fiber is a non-immunogenic non-living biomaterial primarily due to its highly-conserved protein molecular structures across species [3,37,38].…”
This work is an in-depth investigation of the in vitro and in vivo biocompatibility of processed and treated residual human hair samples with intact cuticle layers. The specimens included oxidized hair with no melanin (BLH) and hair with medium- (M-KAP) and low- (L-KAP) levels of keratin associated proteins (KAPs), confirmed through gel electrophoresis, electron microscopy, and trichrome histological staining, in comparison to the untreated regular hair (REG) control. All hair groups, high KAPs (H-KAPs: REG and BLH), M-KAP, and L-KAP, were found to be non-cytotoxic in the adipose fibroblast cell line's response to their extracts based on the ISO 10993-5 medical device biomaterial testing standard. In vivo mouse subcutaneous implantation (ISO 10993-6, local effects) at 2 weeks showed that the samples caused a foreign body response (FBR) with a thin fibrous encapsulation at a mean value of 28% relative skin dermis thickness; but notably, the L-KAP implant mitigated a statistically significant decrease in FBR area compared to H-KAP's (REG and/or BLH) and a lower number of cells, including immune cells of mostly macrophages and mast cells on the biomaterial's surface, normalized to implant and tissue coverage. In the bulk of the capsules, blood vessels and collagen extracellular matrix densities were similar among groups. These findings suggest that small globular KAPs diffuse out of the cortex to the host-biomaterial interface which induce a slightly elevated FBR but limited to the implant's surface vicinity. On-going follow-up research focuses on purer keratin-based macromolecularly organized residual hair biomaterials, those with depleted KAPs, for drug-delivery gel implants as they are deemed the most biocompatible.
“…6) was thin (with 28% mean) compared to a much thicker reaction in pacemaker implants in the mm range at ~ 100% of the dermis thickness [24]. The paper's objective outcome correlated with numerous previous studies on extracted and reassembled keratins and KAPs or the broad term "keratin biomaterials," with or without other accepted polymeric biomaterials, showing good in vitro and in vivo biocompatibilities [10,12,[33][34][35]. In the absence of the hair follicle which is the antigenic region [36] containing intact living cells, the terminal hair shaft or fiber is a non-immunogenic non-living biomaterial primarily due to its highly-conserved protein molecular structures across species [3,37,38].…”
This work is an in-depth investigation of the in vitro and in vivo biocompatibility of processed and treated residual human hair samples with intact cuticle layers. The specimens included oxidized hair with no melanin (BLH) and hair with medium- (M-KAP) and low- (L-KAP) levels of keratin associated proteins (KAPs), confirmed through gel electrophoresis, electron microscopy, and trichrome histological staining, in comparison to the untreated regular hair (REG) control. All hair groups, high KAPs (H-KAPs: REG and BLH), M-KAP, and L-KAP, were found to be non-cytotoxic in the adipose fibroblast cell line's response to their extracts based on the ISO 10993-5 medical device biomaterial testing standard. In vivo mouse subcutaneous implantation (ISO 10993-6, local effects) at 2 weeks showed that the samples caused a foreign body response (FBR) with a thin fibrous encapsulation at a mean value of 28% relative skin dermis thickness; but notably, the L-KAP implant mitigated a statistically significant decrease in FBR area compared to H-KAP's (REG and/or BLH) and a lower number of cells, including immune cells of mostly macrophages and mast cells on the biomaterial's surface, normalized to implant and tissue coverage. In the bulk of the capsules, blood vessels and collagen extracellular matrix densities were similar among groups. These findings suggest that small globular KAPs diffuse out of the cortex to the host-biomaterial interface which induce a slightly elevated FBR but limited to the implant's surface vicinity. On-going follow-up research focuses on purer keratin-based macromolecularly organized residual hair biomaterials, those with depleted KAPs, for drug-delivery gel implants as they are deemed the most biocompatible.
Lymphocytes are crucial to defend against harmful pathogens and sustain adaptive immunity. Developing immunomodulating materials to activate lymphocytes is imperative to induce effective and enduring immune responses. Here, a new polymer serving as a highly efficient activator of B cells is reported and corresponding polymer spheres are synthesized through a droplet‐assisted ternary copolymerization process of ascorbic acid, ethylenediamine, and glyoxal. In‐depth studies are conducted on the polymerization mechanisms and polymer spheres ranging from 250 to 1200 nm with various surface functional groups are synthesized. These prepared polymer materials exhibit remarkable immunomodulatory functions correlated to the polymer spheres' size and surface functional groups, and effective activations on B cells are observed in vivo and in vitro. Through cell phagocytosis experiments and RNA sequencing analysis, it is proposed that the selective phagocytosis of B cells and the presence of CD21 on the B cell membrane contribute to the activation of B cells. This work has extended the realm of immunological research from a unique perspective of chemical synthesis, further substantiating the fundamental research and application potential of designing immunomodulating polymers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.